ArticleTranslational cancer research2024

A retrospective study of anlotinib in patients with persistent, recurrent or metastatic cervical and endometrial cancer.

Lingli Xin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.